Medical Myeloma Treatment: Uncover Key Prognosis & Survival Factors
Key Takeaway
For anyone wondering about Medical Myeloma Treatment: Uncover Key Prognosis & Survival Factors, Medical myeloma treatment encompasses chemotherapy, radiation therapy, and often autologous stem cell transplant, which is proven to improve overall survival, though not a cure. The overall 10-year survival rate for multiple myeloma is approximately 10%. Mirel criteria are utilized to assess pathologic fracture risk, with the primary site of malignancy not being a determining factor.
You are reviewing a 68-year-old patient with known Multiple Myeloma who presents with a painful, non-displaced lytic lesion in the proximal femoral diaphysis. There is no evidence of fracture on plain radiographs. How do you decide whether to proceed with prophylactic surgical stabilization?
Candidate: I would assess the patient's pain, the size of the lesion, and its location. I would use the Mirels Score to determine the fracture risk. If the score is 7 or higher, I would recommend prophylactic stabilization, likely using an intramedullary nail with cement augmentation.
Candidates often simply recite the Mirels criteria without explaining the broader context. A poor answer ignores the systemic disease status (ECOG performance status, life expectancy) and fails to mention the multidisciplinary input (Hematology/Oncology) required to decide if the patient can survive the surgery or if the disease is rapidly progressing.
The perfect answer systematically structures the decision: 1. Clinical Assessment: Evaluate pain character (mechanical vs. rest pain) and clinical performance (ECOG status). 2. Objective Risk Stratification: Apply the Mirels Score (Site, Pain, Lesion size, Lesion type). A score ≥7 indicates a high risk of impending fracture. 3. Systemic Context: Consult Hematology to confirm the patient is stable enough for intervention and that the procedure won't delay critical systemic therapy. 4. Multidisciplinary Input: Mention the role of Radiation Oncology (pre-operative vs. post-operative focal radiation) in the management of the lesion.
You are planning a posterior decompression and instrumentation for a patient with symptomatic thoracic spinal cord compression secondary to myeloma. The patient has significant lytic destruction of the vertebral body.
How do you modify your standard spinal instrumentation technique to ensure stability in this patient?
Candidate: Because the bone quality is poor due to myeloma, I would use a longer construct, likely two levels above and below the index level. I would also use cement-augmented pedicle screws to increase the pull-out strength in the osteopenic bone.
Failing to mention the risk of cement extravasation is a major oversight. Additionally, simply performing a posterior decompression is often insufficient; poor candidates fail to realize that direct posterior decompression alone may not address anterior compression from the collapsed vertebral body, potentially requiring a costotransversectomy or anterior column reconstruction.
A high-scoring answer addresses: 1. Construct Geometry: Longer fixation (2 levels above/below) to distribute the load across more healthy segments. 2. Implant Fixation: Mandatory cement-augmented pedicle screws due to reduced bone modulus/density. 3. Decompression Strategy: Discussing that if the tumor is purely anterior, posterior laminectomy may be inadequate, requiring an anterior or transpedicular approach. 4. Technical Safety: Emphasizing real-time intraoperative fluoroscopy/neuromonitoring and the use of high-viscosity cement to minimize leakage risk.
